BACITRACIN ZINC-POLYMYXIN B SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bacitracin Zinc-polymyxin B Sulfate, and what generic alternatives are available?
Bacitracin Zinc-polymyxin B Sulfate is a drug marketed by Naska and is included in one NDA.
The generic ingredient in BACITRACIN ZINC-POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bacitracin Zinc-polymyxin B Sulfate
A generic version of BACITRACIN ZINC-POLYMYXIN B SULFATE was approved as bacitracin zinc; polymyxin b sulfate by BAUSCH AND LOMB on January 26th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BACITRACIN ZINC-POLYMYXIN B SULFATE?
- What are the global sales for BACITRACIN ZINC-POLYMYXIN B SULFATE?
- What is Average Wholesale Price for BACITRACIN ZINC-POLYMYXIN B SULFATE?
Summary for BACITRACIN ZINC-POLYMYXIN B SULFATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
DailyMed Link: | BACITRACIN ZINC-POLYMYXIN B SULFATE at DailyMed |
Recent Clinical Trials for BACITRACIN ZINC-POLYMYXIN B SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Glaxo Wellcome | N/A |
National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
US Patents and Regulatory Information for BACITRACIN ZINC-POLYMYXIN B SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Naska | BACITRACIN ZINC-POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;TOPICAL | 062849-001 | Nov 13, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |